COMPLIANCE MATTERS
Compliance & Accreditation
IPIC 2025 is organised by IPOPI. The Congress is provided to international HCPs, with the majority attending from Europe/USA, and strictly adheres to the EFPIA Code of Practice.
EFPIA CODE (Pharmaceutical Industry)
Access Control and Participant Identification
To ensure full compliance with the EFPIA Code of Practice, IPIC 2025 applies strict access control procedures to protect the integrity of scientific and promotional content.
- Access Restriction:
The general public, including patients, will not be permitted to enter areas designated exclusively for Healthcare Professionals (HCPs), such as the exhibition hall or industry symposia. These spaces may contain promotional or scientific materials intended solely for qualified audiences.
- Badge Identification System:
A clear and unmistakable badge system will identify each participant category (e.g., HCP, Industry, Patient, Press).
- Colour Coding:
Distinct visual markers (such as colour strips or coloured text, e.g., “MEDICAL” in blue) will be used to facilitate quick and easy identification by staff, security, and exhibitors.
- Controlled Entry:
Participants’ access will be strictly managed according to badge type, ensuring only authorized individuals enter specific areas (e.g., patients will not have access to industry symposia).
- Scientific Integrity:
In accordance with EACCME® standards, all scientific sessions must remain free from commercial influence. Sponsor logos, advertisements, or branded materials are not permitted within meeting rooms or during scientific presentations.
Promotional displays and sponsor branding may be placed only in designated external exhibition areas.
UEMS/EACCME® Compliance Requirements
In line with the UEMS–EACCME® criteria:
- The name or logo of a sponsor must not appear on participant badges.
- Sponsors’ names, logos, or brand names must not be used in the title of the scientific program, session, or lecture.
- Branding and promotional materials are strictly prohibited within the official scientific program or lecture areas.
Medical Education Accreditation (CME)
The IPIC 2025 Congress is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®), an institution of the European Union of Medical Specialists (UEMS).
Participants are eligible to receive up to 13.5 European CME Credits (ECMEC®s), reflecting the Congress’s commitment to maintaining the highest standards in independent medical education.
Data Protection (GDPR)
IPIC 2025 fully complies with European Regulation (EU) 2016/679 – the General Data Protection Regulation (GDPR).
Clear and transparent data protection policies are in place to govern the collection, processing, and storage of participants’ personal data.
Participants have the following rights regarding their personal information:
- Right of Access – to obtain confirmation and details of how their data is used.
- Right to Rectification – to request correction of any inaccurate or incomplete data.
- Right to Object – to oppose certain processing activities in accordance with the Regulation.
All data handling is carried out in line with IPIC 2025’s official Privacy and Data Protection Policy.
Official Registration
The official IPIC 2025 registration is available only through the Congress website.
Participants are strongly advised to use the official platform for registration and accommodation bookings.
Engaging with unofficial or third-party websites may lead to fraud, misrepresentation, or financial loss, and IPIC 2025 accepts no responsibility for registrations made outside the official system.
MedTech Europe CODE (Medical Technology Industry)
IPIC 2025 has been assessed and approved by EthicalMedTech through its Conference Vetting System (CVS) and is fully compliant with the MedTech Europe Code of Ethical Business Practice.
This approval confirms that the event meets the highest standards of ethical collaboration between the medical technology industry and healthcare professionals.
AIM Group International – IPIC2025 Organising Secretariat is appointed MEDTECH Trusted Partner. For any assistance please contact ipic2025@aimgroup.eu
AIFA
Official Italian Agency for AIFA Procedure
Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124) in attached.
The request of authorization must be submitted within 60 days before the starting date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:
AIM Group International – AIM Education S.r.l.
Cristina Ghidoli
Via G. Ripamonti, 129
20141 Milan, Italy
TEL +39 02 56601.1
FAX +39 02-70048585
